Zacks
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes
Urmimala Biswas
5 min read

In This Article:

Investors are closely watching April 2, the long-anticipated “Liberation Day,” which has finally arrived. Financial markets are already getting jittery. Trump’s latest move to reshape trade policies by imposing a sweeping new round of tariffs (to be announced in just a few hours) may lead to a recession, as per many market watchers. Goldman Sachs recently raised its recession forecast from 20% to 35%, citing concerns that these tariffs could slow down business activity, drive up consumer prices and weaken economic confidence. With unemployment still low but consumer sentiment faltering, an economic downturn appears more imminent than before.

Economists are apprehensive that these tariffs could trigger negative repercussions, from increased costs for businesses that rely on imported goods to a slowdown in hiring and wage growth. Even before the tariffs take full effect, Wall Street firms have begun lowering their GDP growth projections, reflecting fears of an economic contraction.

At a time when market volatility is nearing its peak, it is prudent for investors to focus on long-term stability rather than short-term gains. The medical device industry has historically been a happy hunting ground for investors during periods of market upheaval. Despite facing short-term headwinds such as tariffs, healthcare labor supply issues and persistent cost escalation, the long-term outlook for medical device stocks remains highly promising. As we navigate through 2025, certain companies, such as Masimo MASI, Boston Scientific BSX, and Hims & Hers Health HIMS, stand out for their ability to counter these challenges while maintaining strong financial performance and market leadership.

Medical Device Stocks: A Safe Bet

Over the past couple of years, advancements in AI and predictive analytics have rapidly revolutionized the Medical device industry, driving innovation in diagnostics, patient monitoring and personalized treatment. AI-powered algorithms are enabling medical devices to analyze vast datasets in real time, providing accurate predictions and actionable insights for clinicians. Predictive analytics enhances device performance by identifying potential failures and optimizing maintenance schedules, ensuring reliability and reducing costs. In patient care, AI-integrated devices are advancing early disease detection and risk assessment, leading to improved outcomes.

In 2025, the rapid adoption of generative Artificial Intelligence (genAI) and digital therapeutics is expected to take this industry by storm. GenAI has already started to showcase its proficiency across a range of healthcare fields, from administrative tasks to critical areas, including clinical trials. Global AI in the healthcare market is currently projected to witness a CAGR of 38.5% from 2024 to 2030.

Terms and Privacy Policy
Your Privacy Choices
Utah Privacy Notice
More Info

Recommended Stories